News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/September-2017/media_5c01297_dollars_stethoscope.jpg)
Low-dose CT screen for lung cancer cost effective for high-risk patients
Key clinical point: Low-dose CT might be most cost effective for women and current smokers. Major finding: On average, screening for lung cancer...
Medicare patients who are at high risk for lung cancer would be able to get screening using low-dose computed tomography under a proposed national coverage decision announced Nov. 10.
“The evidence is sufficient to add a lung cancer screening counseling and shared decision making visit, and for appropriate beneficiaries, screening for lung cancer with low-dose computed tomography, once per year, as an additional preventive service benefit under the Medicare program,” officials from the Centers for Medicare & Medicaid Services wrote in the proposed decision.
The agency would strictly limit eligibility criteria for low-dose CT screening. Appropriate patients would be 55-74 years old, show no signs of lung disease, and have a smoking history of at least 30 pack-years. Further, appropriate patients would be either current smokers or would have quit within the past 15 years. The written order for the low-dose CT screening must come after a lung cancer screening counseling and shared decision making visit with a physician or qualified nonphysician practitioner. Subsequent screenings orders could be received in writing during any appropriate visit.
The proposed coverage national decision comes despite a recommendation from the Medicare Evidence Development and Coverage Advisory Committee earlier this year to not cover low-dose CT screening. A study published Nov. 5 in the New England Journal of Medicine found low-dose CT screening cost effective for patients at high risk for lung cancer (2014;371:1793-802).
CMS will accept comments on the proposed coverage decision for 30 days, starting Nov. 10.
Key clinical point: Low-dose CT might be most cost effective for women and current smokers. Major finding: On average, screening for lung cancer...